Bausch Health Announces SILIQ Now Listed Under Alberta's Public Drug Plan For Eligible Moderate To Severe Plaque Psoriasis Patients
Share
Why It Matters
Bausch Health's psoriasis medicine SILIQ can now be prescribed to more patients in Alberta with help from the government's drug plan. This means more people can afford the medicine, which could help the company sell more of it.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.